Literature DB >> 24741079

Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences.

Mateja M Jelen1, Zigui Chen2, Boštjan J Kocjan1, Felicity J Burt3, Paul K S Chan4, Diego Chouhy5, Catharina E Combrinck3, François Coutlée6, Christine Estrade7, Alex Ferenczy8, Alison Fiander9, Eduardo L Franco10, Suzanne M Garland11, Adriana A Giri5, Joaquín Víctor González12, Arndt Gröning13, Kerstin Heidrich13, Sam Hibbitts9, Lea Hošnjak1, Tommy N M Luk14, Karina Marinic15, Toshihiko Matsukura16, Anna Neumann13, Anja Oštrbenk1, Maria Alejandra Picconi12, Harriet Richardson17, Martin Sagadin1, Roland Sahli7, Riaz Y Seedat18, Katja Seme1, Alberto Severini19, Jessica L Sinchi15, Jana Smahelova20, Sepehr N Tabrizi11, Ruth Tachezy20, Sarah Tohme19, Virgilijus Uloza21, Astra Vitkauskiene22, Yong Wee Wong23, Snježana Zidovec Lepej24, Robert D Burk25, Mario Poljak26.   

Abstract

UNLABELLED: Human papillomavirus type 6 (HPV6) is the major etiological agent of anogenital warts and laryngeal papillomas and has been included in both the quadrivalent and nonavalent prophylactic HPV vaccines. This study investigated the global genomic diversity of HPV6, using 724 isolates and 190 complete genomes from six continents, and the association of HPV6 genomic variants with geographical location, anatomical site of infection/disease, and gender. Initially, a 2,800-bp E5a-E5b-L1-LCR fragment was sequenced from 492/530 (92.8%) HPV6-positive samples collected for this study. Among them, 130 exhibited at least one single nucleotide polymorphism (SNP), indel, or amino acid change in the E5a-E5b-L1-LCR fragment and were sequenced in full. A global alignment and maximum likelihood tree of 190 complete HPV6 genomes (130 fully sequenced in this study and 60 obtained from sequence repositories) revealed two variant lineages, A and B, and five B sublineages: B1, B2, B3, B4, and B5. HPV6 (sub)lineage-specific SNPs and a 960-bp representative region for whole-genome-based phylogenetic clustering within the L2 open reading frame were identified. Multivariate logistic regression analysis revealed that lineage B predominated globally. Sublineage B3 was more common in Africa and North and South America, and lineage A was more common in Asia. Sublineages B1 and B3 were associated with anogenital infections, indicating a potential lesion-specific predilection of some HPV6 sublineages. Females had higher odds for infection with sublineage B3 than males. In conclusion, a global HPV6 phylogenetic analysis revealed the existence of two variant lineages and five sublineages, showing some degree of ethnogeographic, gender, and/or disease predilection in their distribution. IMPORTANCE: This study established the largest database of globally circulating HPV6 genomic variants and contributed a total of 130 new, complete HPV6 genome sequences to available sequence repositories. Two HPV6 variant lineages and five sublineages were identified and showed some degree of association with geographical location, anatomical site of infection/disease, and/or gender. We additionally identified several HPV6 lineage- and sublineage-specific SNPs to facilitate the identification of HPV6 variants and determined a representative region within the L2 gene that is suitable for HPV6 whole-genome-based phylogenetic analysis. This study complements and significantly expands the current knowledge of HPV6 genetic diversity and forms a comprehensive basis for future epidemiological, evolutionary, functional, pathogenicity, vaccination, and molecular assay development studies.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24741079      PMCID: PMC4054425          DOI: 10.1128/JVI.00621-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types.

Authors:  Davit Bzhalava; Peng Guan; Silvia Franceschi; Joakim Dillner; Gary Clifford
Journal:  Virology       Date:  2013-08-05       Impact factor: 3.616

2.  Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.

Authors:  Kristina Fujs Komloš; Boštjan J Kocjan; Pavle Košorok; Boštjan Luzar; Leon Meglič; Marko Potočnik; Irena Hočevar-Boltežar; Nina Gale; Katja Seme; Mario Poljak
Journal:  J Med Virol       Date:  2012-08       Impact factor: 2.327

3.  Novel HPV-6 variants of human papillomavirus causing recurrent respiratory papillomatosis in southern Africa.

Authors:  C E Combrinck; R Y Seedat; C Randall; Y Roodt; F J Burt
Journal:  Epidemiol Infect       Date:  2011-08-30       Impact factor: 2.451

4.  Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas.

Authors:  Agustín Enrique Ure; Ola Forslund
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

5.  Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with "low-risk" HPV genotypes 6 and 11.

Authors:  Alyssa M Cornall; Jennifer M Roberts; Suzanne M Garland; Richard J Hillman; Andrew E Grulich; Sepehr N Tabrizi
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

6.  Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years.

Authors:  Boštjan J Kocjan; Nina Gale; Irena Hočevar Boltežar; Katja Seme; Kristina Fujs Komloš; Lea Hošnjak; Polona J Maver; Mateja M Jelen; Irena Zupanič Pajnič; Jože Balažic; Mario Poljak
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

7.  Nucleotide and phylogenetic analysis of human papillomavirus types 6 and 11 isolated from recurrent respiratory papillomatosis in Brazil.

Authors:  Renata Prandini Adum de Matos; Laura Sichero; Isabela Mazuco Mansur; Caroline Measso do Bonfim; Cíntia Bittar; Rodrigo Lacerda Nogueira; Daniel Salgado Küpper; Fabiana Cardoso Pereira Valera; Maurício Lacerda Nogueira; Luisa Lina Villa; Marilia Freitas Calmon; Paula Rahal
Journal:  Infect Genet Evol       Date:  2013-03-01       Impact factor: 3.342

8.  Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis.

Authors:  Christian Ulrich Huebbers; Simon Florian Preuss; Jutta Kolligs; Julia Vent; Markus Stenner; Ulrike Wieland; Steffi Silling; Uta Drebber; Ernst-Jan M Speel; Jens Peter Klussmann
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia.

Authors:  Jennifer A Danielewski; Suzanne M Garland; Jenny McCloskey; Richard J Hillman; Sepehr N Tabrizi
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

10.  Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70.

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Rob DeSalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Robert D Burk
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more
  17 in total

1.  HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study.

Authors:  Ema Flores-Díaz; Karen A Sereday; Silvaneide Ferreira; Bradley Sirak; João Simão Sobrinho; Maria Luiza Baggio; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

2.  Lack of Association between Human Papillomavirus Types 6 and 11 Genetic Variants and Cervical Abnormalities: The Ludwig-McGill Cohort Study.

Authors:  Laura Sichero; Mariam El-Zein; Silvaneide Ferreira; Eduardo L Franco; Luisa L Villa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-03-13       Impact factor: 4.254

3.  Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences.

Authors:  Mateja M Jelen; Zigui Chen; Boštjan J Kocjan; Lea Hošnjak; Felicity J Burt; Paul K S Chan; Diego Chouhy; Catharina E Combrinck; Christine Estrade; Alison Fiander; Suzanne M Garland; Adriana A Giri; Joaquín Víctor González; Arndt Gröning; Sam Hibbitts; Tommy N M Luk; Karina Marinic; Toshihiko Matsukura; Anna Neumann; Anja Oštrbenk; Maria Alejandra Picconi; Martin Sagadin; Roland Sahli; Riaz Y Seedat; Katja Seme; Alberto Severini; Jessica L Sinchi; Jana Smahelova; Sepehr N Tabrizi; Ruth Tachezy; Sarah Tohme Faybush; Virgilijus Uloza; Ingrida Uloziene; Yong Wee Wong; Snježana Židovec Lepej; Robert D Burk; Mario Poljak
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

Review 4.  Papillomaviruses: Viral evolution, cancer and evolutionary medicine.

Authors:  Ignacio G Bravo; Marta Félez-Sánchez
Journal:  Evol Med Public Health       Date:  2015-01-28

5.  Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis.

Authors:  Caroline Measso do Bonfim; João Simão Sobrinho; Rodrigo Lacerda Nogueira; Daniel Salgado Kupper; Fabiana Cardoso Pereira Valera; Maurício Lacerda Nogueira; Luisa Lina Villa; Paula Rahal; Laura Sichero
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

6.  Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer.

Authors:  Yuri Tenjimbayashi; Mamiko Onuki; Yusuke Hirose; Seiichiro Mori; Yoshiyuki Ishii; Takamasa Takeuchi; Nobutaka Tasaka; Toyomi Satoh; Tohru Morisada; Takashi Iwata; Shingo Miyamoto; Koji Matsumoto; Akihiko Sekizawa; Iwao Kukimoto
Journal:  Infect Agent Cancer       Date:  2017-08-04       Impact factor: 2.965

7.  Characterisation of complete high- and low-risk human papillomavirus genomes isolated from cervical specimens in southern Brazil.

Authors:  Gisele R de Oliveira; Juliana D Siqueira; Fabiana Finger-Jardim; Valdimara C Vieira; Ronald L Silva; Carla V Gonçalves; Esmeralda A Soares; Ana Maria Barral de Martinez; Marcelo A Soares
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-10       Impact factor: 2.743

8.  Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions.

Authors:  Melanie Rijsbergen; Rianne Rijneveld; Marina Todd; Gary L Feiss; Stijn T P Kouwenhoven; Koen D Quint; Dirk C J G van Alewijk; Maurits N C de Koning; Erica S Klaassen; Jacobus Burggraaf; Robert Rissmann; Mariëtte I E van Poelgeest
Journal:  Br J Clin Pharmacol       Date:  2020-09-28       Impact factor: 4.335

9.  Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Rob DeSalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Paul K S Chan; Robert D Burk
Journal:  Virology       Date:  2018-01-11       Impact factor: 3.616

10.  Determination of the complete genome and functional analysis of HPV6 isolate VBD19/10 from a patient with aggressive recurrent respiratory papillomatosis.

Authors:  R Y Seedat; C E Combrinck; P A Bester; J-Y Lee; F J Burt
Journal:  Epidemiol Infect       Date:  2016-03-02       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.